• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Adastra Holdings Ltd (OP: XTXXF )

    0.0600 UNCHANGED
    Last Price Updated: 12:55 PM EDT, Oct 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Adastra Holdings Ltd

    Canadian Cannabis Concentrates Producer, Adastra, Reports Third Year Of Record Revenue, But Also Higher Losses
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stock Gainers And Losers From August 24, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Adastra Holdings Appoints Smoke Wallin As New Director
    Adastra Holdings Ltd. (OTCPK: XTXXF) (FRA: D2EP) appointed Smoke Wallin to the company's board of directors. Wallin Responds 
    Via Benzinga
    Canadian Marijuana Stock Posts 133% YoY Revenue Growth, But Also 124% Higher Net Loss In Q2
    Candian marijuana operator Adastra Holdings Ltd. (OTC: XTXXF)(CSE:XTRX)(FRA:D2EP) reported Thursday financial results for the three months ended June 30, 2023, disclosing net revenue of CA$7.1 million,... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Canadian Weed Company Adastra Reports Triple-Digit Q1 Revenue Growth, What's Behind The Figures?
    Cannabis producer Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTC: XTXXF) reported on Tuesday financial results for the three months ended March 31, 2023. 
    Via Benzinga
    Adastra FY22 Revenue Grows 136%, Here Is What You Need To Know
    Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) FY 2022 net revenue increased 136% to CA$13.3 million ($9.8 million), compared to CA$5.6 million in FY 2021. FY 2022 Financial Highlights Gross... 
    Via Benzinga
    Adastra Stock Skyrockets On Record Shipment Volume, Following The News Of Civil Lawsuit
    Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP) has been served with a civil claim filed in the Supreme Court of British Columbia pursuant to the Class Proceedings Act, R.S.B.C. 1996, c. 50... 
    Via Benzinga
    Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
    Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial 
    Via Benzinga
    Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
    Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been... 
    Via Benzinga
    Adastra Clarifies Health Canada Approval To Handle Cocaine
    Adastra Labs Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) provided clarification regarding its receipt of Health Canada approval for the amendment to include cocaine under its controlled substances... 
    Via Benzinga
    Canadian Weed Company's Plan To Produce Cocaine Shocks Local Leader, Opposition Questions Drug Experiment
    A Langley, British Columbia, cannabis company got the green light from Health Canada to produce and sell cocaine earlier this month, but the province's Premier says he was unaware of the mo 
    Via Benzinga
    Canada Gives This Cannabis Company The Green Light To Handle Cocaine, Psilocybin
    Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) (OTCPK: XTXXF) reported on Wednesday that Adastra Labs got the green light from Health Canada earlier this month for its amendment to include cocaine as a... 
    Via Benzinga
    Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
    Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... 
    Via Benzinga
    Adastra Q3 Revenue Grows 110% YoY To $2.83M
    Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX)(FRA:D2EP), released its financial results for the three and nine months ended September 30, 2022. Q3 2022 Financial Highlights 
    Via Benzinga
    Adastra Steps Into Magic Mushrooms! Gets Dealer's License For Psilocybin And Psilocin
    Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has received its Controlled Drug and Substances Dealer's License on August 24, 2022. This license allows Adastra to process psilocybin and... 
    Via Benzinga
    Cannabis Movers & Shakers: OnPoint Laboratories, Neptune Wellness, Adastra Holdings & Cannaverse Technologies
    OnPoint Laboratories Names Samuel Richard CEO & Equity Partner OnPoint Laboratories has appointed Samuel Richard to serve as CEO and equity partner. Richard succeeds Jeff Cardot, founder and current... 
    Via Benzinga
    Adastra Holdings Reports Record Revenue In 2021, Here Are The Details
    Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) has filed its consolidated financial statements and related management discussion and analysis for the year ended December 31, 2021. 
    Via Benzinga
    Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services
    Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) submitted medical sales license application to Health Canada on April 1, 2022. A medical sales license would permit Adastra to perform the... 
    Via Benzinga
    Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD
    Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE:XTRX) (FRA:... 
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.